nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—PTGS1—breast cancer	0.267	0.636	CbGaD
Nabumetone—PTGS2—breast cancer	0.153	0.364	CbGaD
Nabumetone—MPO—Carboplatin—breast cancer	0.115	0.43	CbGbCtD
Nabumetone—CYP1A2—Anastrozole—breast cancer	0.0612	0.229	CbGbCtD
Nabumetone—CYP1A2—Toremifene—breast cancer	0.056	0.209	CbGbCtD
Nabumetone—CYP1A2—Tamoxifen—breast cancer	0.0205	0.0764	CbGbCtD
Nabumetone—CYP1A2—Fluorouracil—breast cancer	0.0151	0.0563	CbGbCtD
Nabumetone—Melatonin—MT3—breast cancer	0.00148	0.322	CrCbGaD
Nabumetone—Melatonin—NQO2—breast cancer	0.00126	0.273	CrCbGaD
Nabumetone—MPO—epithelium—breast cancer	0.000717	0.063	CbGeAlD
Nabumetone—MPO—skin of body—breast cancer	0.000682	0.0599	CbGeAlD
Nabumetone—CYP1A2—nipple—breast cancer	0.000583	0.0512	CbGeAlD
Nabumetone—MPO—pituitary gland—breast cancer	0.000582	0.0511	CbGeAlD
Nabumetone—MPO—adrenal gland—breast cancer	0.00052	0.0457	CbGeAlD
Nabumetone—PTGS1—nipple—breast cancer	0.000505	0.0444	CbGeAlD
Nabumetone—MPO—bone marrow—breast cancer	0.000503	0.0442	CbGeAlD
Nabumetone—MPO—endocrine gland—breast cancer	0.000451	0.0396	CbGeAlD
Nabumetone—Melatonin—CYP1B1—breast cancer	0.000426	0.0925	CrCbGaD
Nabumetone—PTGS2—embryo—breast cancer	0.000399	0.035	CbGeAlD
Nabumetone—PTGS1—epithelium—breast cancer	0.00034	0.0299	CbGeAlD
Nabumetone—PTGS2—epithelium—breast cancer	0.000325	0.0286	CbGeAlD
Nabumetone—PTGS1—skin of body—breast cancer	0.000324	0.0284	CbGeAlD
Nabumetone—Melatonin—CYP19A1—breast cancer	0.000313	0.0679	CrCbGaD
Nabumetone—MPO—lymph node—breast cancer	0.000312	0.0274	CbGeAlD
Nabumetone—PTGS2—skin of body—breast cancer	0.000309	0.0272	CbGeAlD
Nabumetone—PTGS1—endometrium—breast cancer	0.000305	0.0268	CbGeAlD
Nabumetone—Naproxen—PTGS1—breast cancer	0.000292	0.0635	CrCbGaD
Nabumetone—PTGS2—endometrium—breast cancer	0.000292	0.0256	CbGeAlD
Nabumetone—Melatonin—ESR1—breast cancer	0.000288	0.0625	CrCbGaD
Nabumetone—PTGS1—uterus—breast cancer	0.000281	0.0247	CbGeAlD
Nabumetone—PTGS1—pituitary gland—breast cancer	0.000276	0.0243	CbGeAlD
Nabumetone—PTGS1—adipose tissue—breast cancer	0.000275	0.0242	CbGeAlD
Nabumetone—PTGS2—uterus—breast cancer	0.000269	0.0236	CbGeAlD
Nabumetone—PTGS2—pituitary gland—breast cancer	0.000264	0.0232	CbGeAlD
Nabumetone—PTGS2—adipose tissue—breast cancer	0.000263	0.0231	CbGeAlD
Nabumetone—PTGS1—female reproductive system—breast cancer	0.000253	0.0222	CbGeAlD
Nabumetone—CYP1A2—endocrine gland—breast cancer	0.000247	0.0217	CbGeAlD
Nabumetone—PTGS1—adrenal gland—breast cancer	0.000247	0.0217	CbGeAlD
Nabumetone—PTGS2—female reproductive system—breast cancer	0.000242	0.0212	CbGeAlD
Nabumetone—PTGS2—adrenal gland—breast cancer	0.000236	0.0207	CbGeAlD
Nabumetone—PTGS1—female gonad—breast cancer	0.00023	0.0202	CbGeAlD
Nabumetone—Melatonin—CYP1A1—breast cancer	0.00023	0.05	CrCbGaD
Nabumetone—PTGS2—bone marrow—breast cancer	0.000228	0.02	CbGeAlD
Nabumetone—PTGS2—female gonad—breast cancer	0.00022	0.0193	CbGeAlD
Nabumetone—PTGS1—endocrine gland—breast cancer	0.000214	0.0188	CbGeAlD
Nabumetone—PTGS2—endocrine gland—breast cancer	0.000204	0.018	CbGeAlD
Nabumetone—Naproxen—PTGS2—breast cancer	0.000167	0.0363	CrCbGaD
Nabumetone—Naproxen—ALB—breast cancer	0.000149	0.0323	CrCbGaD
Nabumetone—PTGS1—lymph node—breast cancer	0.000148	0.013	CbGeAlD
Nabumetone—PTGS2—lymph node—breast cancer	0.000141	0.0124	CbGeAlD
Nabumetone—Agranulocytosis—Epirubicin—breast cancer	6.02e-05	0.000294	CcSEcCtD
Nabumetone—Pneumonia—Doxorubicin—breast cancer	6.01e-05	0.000293	CcSEcCtD
Nabumetone—Shock—Docetaxel—breast cancer	6e-05	0.000293	CcSEcCtD
Nabumetone—Pruritus—Fluorouracil—breast cancer	5.98e-05	0.000292	CcSEcCtD
Nabumetone—Thrombocytopenia—Docetaxel—breast cancer	5.98e-05	0.000291	CcSEcCtD
Nabumetone—Visual impairment—Methotrexate—breast cancer	5.97e-05	0.000291	CcSEcCtD
Nabumetone—Confusional state—Capecitabine—breast cancer	5.96e-05	0.000291	CcSEcCtD
Nabumetone—Feeling abnormal—Paclitaxel—breast cancer	5.93e-05	0.000289	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Doxorubicin—breast cancer	5.92e-05	0.000289	CcSEcCtD
Nabumetone—Oedema—Capecitabine—breast cancer	5.91e-05	0.000288	CcSEcCtD
Nabumetone—Gastrointestinal pain—Paclitaxel—breast cancer	5.89e-05	0.000287	CcSEcCtD
Nabumetone—Diarrhoea—Gemcitabine—breast cancer	5.88e-05	0.000287	CcSEcCtD
Nabumetone—Renal failure—Doxorubicin—breast cancer	5.87e-05	0.000286	CcSEcCtD
Nabumetone—Erythema multiforme—Methotrexate—breast cancer	5.85e-05	0.000286	CcSEcCtD
Nabumetone—Dizziness—Irinotecan—breast cancer	5.84e-05	0.000285	CcSEcCtD
Nabumetone—Haemoglobin—Epirubicin—breast cancer	5.82e-05	0.000284	CcSEcCtD
Nabumetone—Stomatitis—Doxorubicin—breast cancer	5.82e-05	0.000284	CcSEcCtD
Nabumetone—Jaundice—Doxorubicin—breast cancer	5.82e-05	0.000284	CcSEcCtD
Nabumetone—Anorexia—Docetaxel—breast cancer	5.82e-05	0.000284	CcSEcCtD
Nabumetone—Shock—Capecitabine—breast cancer	5.81e-05	0.000284	CcSEcCtD
Nabumetone—Haemorrhage—Epirubicin—breast cancer	5.79e-05	0.000283	CcSEcCtD
Nabumetone—Diarrhoea—Fluorouracil—breast cancer	5.79e-05	0.000282	CcSEcCtD
Nabumetone—Thrombocytopenia—Capecitabine—breast cancer	5.79e-05	0.000282	CcSEcCtD
Nabumetone—Tinnitus—Methotrexate—breast cancer	5.77e-05	0.000282	CcSEcCtD
Nabumetone—Urticaria—Paclitaxel—breast cancer	5.72e-05	0.000279	CcSEcCtD
Nabumetone—Hyperhidrosis—Capecitabine—breast cancer	5.71e-05	0.000279	CcSEcCtD
Nabumetone—Haematuria—Doxorubicin—breast cancer	5.69e-05	0.000278	CcSEcCtD
Nabumetone—Abdominal pain—Paclitaxel—breast cancer	5.69e-05	0.000278	CcSEcCtD
Nabumetone—Body temperature increased—Paclitaxel—breast cancer	5.69e-05	0.000278	CcSEcCtD
Nabumetone—Anorexia—Capecitabine—breast cancer	5.63e-05	0.000275	CcSEcCtD
Nabumetone—Vomiting—Mitoxantrone—breast cancer	5.61e-05	0.000274	CcSEcCtD
Nabumetone—Vomiting—Irinotecan—breast cancer	5.61e-05	0.000274	CcSEcCtD
Nabumetone—Dizziness—Fluorouracil—breast cancer	5.59e-05	0.000273	CcSEcCtD
Nabumetone—Visual impairment—Epirubicin—breast cancer	5.58e-05	0.000272	CcSEcCtD
Nabumetone—Agranulocytosis—Doxorubicin—breast cancer	5.57e-05	0.000272	CcSEcCtD
Nabumetone—Rash—Mitoxantrone—breast cancer	5.57e-05	0.000272	CcSEcCtD
Nabumetone—Rash—Irinotecan—breast cancer	5.57e-05	0.000272	CcSEcCtD
Nabumetone—Dermatitis—Irinotecan—breast cancer	5.56e-05	0.000271	CcSEcCtD
Nabumetone—Dermatitis—Mitoxantrone—breast cancer	5.56e-05	0.000271	CcSEcCtD
Nabumetone—Chills—Methotrexate—breast cancer	5.56e-05	0.000271	CcSEcCtD
Nabumetone—Headache—Mitoxantrone—breast cancer	5.53e-05	0.00027	CcSEcCtD
Nabumetone—Headache—Irinotecan—breast cancer	5.53e-05	0.00027	CcSEcCtD
Nabumetone—Insomnia—Docetaxel—breast cancer	5.52e-05	0.000269	CcSEcCtD
Nabumetone—Paraesthesia—Docetaxel—breast cancer	5.48e-05	0.000267	CcSEcCtD
Nabumetone—Erythema multiforme—Epirubicin—breast cancer	5.48e-05	0.000267	CcSEcCtD
Nabumetone—Alopecia—Methotrexate—breast cancer	5.47e-05	0.000267	CcSEcCtD
Nabumetone—Vomiting—Gemcitabine—breast cancer	5.47e-05	0.000267	CcSEcCtD
Nabumetone—Dyspnoea—Docetaxel—breast cancer	5.44e-05	0.000265	CcSEcCtD
Nabumetone—Somnolence—Docetaxel—breast cancer	5.43e-05	0.000265	CcSEcCtD
Nabumetone—Rash—Gemcitabine—breast cancer	5.42e-05	0.000264	CcSEcCtD
Nabumetone—Dermatitis—Gemcitabine—breast cancer	5.42e-05	0.000264	CcSEcCtD
Nabumetone—Tinnitus—Epirubicin—breast cancer	5.4e-05	0.000263	CcSEcCtD
Nabumetone—Haemoglobin—Doxorubicin—breast cancer	5.39e-05	0.000263	CcSEcCtD
Nabumetone—Headache—Gemcitabine—breast cancer	5.39e-05	0.000263	CcSEcCtD
Nabumetone—Vomiting—Fluorouracil—breast cancer	5.38e-05	0.000262	CcSEcCtD
Nabumetone—Dyspepsia—Docetaxel—breast cancer	5.37e-05	0.000262	CcSEcCtD
Nabumetone—Haemorrhage—Doxorubicin—breast cancer	5.36e-05	0.000261	CcSEcCtD
Nabumetone—Insomnia—Capecitabine—breast cancer	5.34e-05	0.000261	CcSEcCtD
Nabumetone—Rash—Fluorouracil—breast cancer	5.33e-05	0.00026	CcSEcCtD
Nabumetone—Dermatitis—Fluorouracil—breast cancer	5.33e-05	0.00026	CcSEcCtD
Nabumetone—Paraesthesia—Capecitabine—breast cancer	5.31e-05	0.000259	CcSEcCtD
Nabumetone—Decreased appetite—Docetaxel—breast cancer	5.31e-05	0.000259	CcSEcCtD
Nabumetone—Hypersensitivity—Paclitaxel—breast cancer	5.3e-05	0.000259	CcSEcCtD
Nabumetone—Headache—Fluorouracil—breast cancer	5.3e-05	0.000258	CcSEcCtD
Nabumetone—Dyspnoea—Capecitabine—breast cancer	5.27e-05	0.000257	CcSEcCtD
Nabumetone—Fatigue—Docetaxel—breast cancer	5.26e-05	0.000257	CcSEcCtD
Nabumetone—Nausea—Mitoxantrone—breast cancer	5.24e-05	0.000256	CcSEcCtD
Nabumetone—Nausea—Irinotecan—breast cancer	5.24e-05	0.000256	CcSEcCtD
Nabumetone—Constipation—Docetaxel—breast cancer	5.22e-05	0.000255	CcSEcCtD
Nabumetone—Dyspepsia—Capecitabine—breast cancer	5.2e-05	0.000254	CcSEcCtD
Nabumetone—Chills—Epirubicin—breast cancer	5.2e-05	0.000254	CcSEcCtD
Nabumetone—Arrhythmia—Epirubicin—breast cancer	5.18e-05	0.000252	CcSEcCtD
Nabumetone—Visual impairment—Doxorubicin—breast cancer	5.17e-05	0.000252	CcSEcCtD
Nabumetone—Asthenia—Paclitaxel—breast cancer	5.17e-05	0.000252	CcSEcCtD
Nabumetone—Decreased appetite—Capecitabine—breast cancer	5.14e-05	0.000251	CcSEcCtD
Nabumetone—Alopecia—Epirubicin—breast cancer	5.12e-05	0.00025	CcSEcCtD
Nabumetone—Nausea—Gemcitabine—breast cancer	5.11e-05	0.000249	CcSEcCtD
Nabumetone—Fatigue—Capecitabine—breast cancer	5.09e-05	0.000248	CcSEcCtD
Nabumetone—Pruritus—Paclitaxel—breast cancer	5.09e-05	0.000248	CcSEcCtD
Nabumetone—Erythema multiforme—Doxorubicin—breast cancer	5.07e-05	0.000247	CcSEcCtD
Nabumetone—Constipation—Capecitabine—breast cancer	5.05e-05	0.000246	CcSEcCtD
Nabumetone—Feeling abnormal—Docetaxel—breast cancer	5.03e-05	0.000245	CcSEcCtD
Nabumetone—Nausea—Fluorouracil—breast cancer	5.02e-05	0.000245	CcSEcCtD
Nabumetone—Ill-defined disorder—Methotrexate—breast cancer	5e-05	0.000244	CcSEcCtD
Nabumetone—Tinnitus—Doxorubicin—breast cancer	5e-05	0.000244	CcSEcCtD
Nabumetone—Gastrointestinal pain—Docetaxel—breast cancer	4.99e-05	0.000243	CcSEcCtD
Nabumetone—Anaemia—Methotrexate—breast cancer	4.98e-05	0.000243	CcSEcCtD
Nabumetone—Flatulence—Epirubicin—breast cancer	4.97e-05	0.000242	CcSEcCtD
Nabumetone—Tension—Epirubicin—breast cancer	4.95e-05	0.000241	CcSEcCtD
Nabumetone—Diarrhoea—Paclitaxel—breast cancer	4.93e-05	0.00024	CcSEcCtD
Nabumetone—Nervousness—Epirubicin—breast cancer	4.9e-05	0.000239	CcSEcCtD
Nabumetone—Feeling abnormal—Capecitabine—breast cancer	4.87e-05	0.000237	CcSEcCtD
Nabumetone—Malaise—Methotrexate—breast cancer	4.86e-05	0.000237	CcSEcCtD
Nabumetone—Vertigo—Methotrexate—breast cancer	4.84e-05	0.000236	CcSEcCtD
Nabumetone—Gastrointestinal pain—Capecitabine—breast cancer	4.83e-05	0.000236	CcSEcCtD
Nabumetone—Abdominal pain—Docetaxel—breast cancer	4.82e-05	0.000235	CcSEcCtD
Nabumetone—Body temperature increased—Docetaxel—breast cancer	4.82e-05	0.000235	CcSEcCtD
Nabumetone—Leukopenia—Methotrexate—breast cancer	4.82e-05	0.000235	CcSEcCtD
Nabumetone—Chills—Doxorubicin—breast cancer	4.81e-05	0.000235	CcSEcCtD
Nabumetone—Arrhythmia—Doxorubicin—breast cancer	4.79e-05	0.000234	CcSEcCtD
Nabumetone—Dizziness—Paclitaxel—breast cancer	4.76e-05	0.000232	CcSEcCtD
Nabumetone—Alopecia—Doxorubicin—breast cancer	4.74e-05	0.000231	CcSEcCtD
Nabumetone—Cough—Methotrexate—breast cancer	4.7e-05	0.000229	CcSEcCtD
Nabumetone—Urticaria—Capecitabine—breast cancer	4.69e-05	0.000229	CcSEcCtD
Nabumetone—Ill-defined disorder—Epirubicin—breast cancer	4.68e-05	0.000228	CcSEcCtD
Nabumetone—Body temperature increased—Capecitabine—breast cancer	4.67e-05	0.000228	CcSEcCtD
Nabumetone—Abdominal pain—Capecitabine—breast cancer	4.67e-05	0.000228	CcSEcCtD
Nabumetone—Anaemia—Epirubicin—breast cancer	4.66e-05	0.000227	CcSEcCtD
Nabumetone—Agitation—Epirubicin—breast cancer	4.64e-05	0.000226	CcSEcCtD
Nabumetone—Flatulence—Doxorubicin—breast cancer	4.6e-05	0.000224	CcSEcCtD
Nabumetone—Tension—Doxorubicin—breast cancer	4.58e-05	0.000223	CcSEcCtD
Nabumetone—Vomiting—Paclitaxel—breast cancer	4.58e-05	0.000223	CcSEcCtD
Nabumetone—Malaise—Epirubicin—breast cancer	4.55e-05	0.000222	CcSEcCtD
Nabumetone—Rash—Paclitaxel—breast cancer	4.54e-05	0.000221	CcSEcCtD
Nabumetone—Dermatitis—Paclitaxel—breast cancer	4.54e-05	0.000221	CcSEcCtD
Nabumetone—Discomfort—Methotrexate—breast cancer	4.53e-05	0.000221	CcSEcCtD
Nabumetone—Nervousness—Doxorubicin—breast cancer	4.53e-05	0.000221	CcSEcCtD
Nabumetone—Vertigo—Epirubicin—breast cancer	4.53e-05	0.000221	CcSEcCtD
Nabumetone—Syncope—Epirubicin—breast cancer	4.52e-05	0.000221	CcSEcCtD
Nabumetone—Leukopenia—Epirubicin—breast cancer	4.51e-05	0.00022	CcSEcCtD
Nabumetone—Headache—Paclitaxel—breast cancer	4.51e-05	0.00022	CcSEcCtD
Nabumetone—Hypersensitivity—Docetaxel—breast cancer	4.5e-05	0.000219	CcSEcCtD
Nabumetone—Palpitations—Epirubicin—breast cancer	4.46e-05	0.000217	CcSEcCtD
Nabumetone—Confusional state—Methotrexate—breast cancer	4.44e-05	0.000216	CcSEcCtD
Nabumetone—Loss of consciousness—Epirubicin—breast cancer	4.43e-05	0.000216	CcSEcCtD
Nabumetone—Cough—Epirubicin—breast cancer	4.4e-05	0.000215	CcSEcCtD
Nabumetone—Anaphylactic shock—Methotrexate—breast cancer	4.4e-05	0.000215	CcSEcCtD
Nabumetone—Asthenia—Docetaxel—breast cancer	4.38e-05	0.000214	CcSEcCtD
Nabumetone—Hypertension—Epirubicin—breast cancer	4.35e-05	0.000212	CcSEcCtD
Nabumetone—Hypersensitivity—Capecitabine—breast cancer	4.35e-05	0.000212	CcSEcCtD
Nabumetone—Ill-defined disorder—Doxorubicin—breast cancer	4.33e-05	0.000211	CcSEcCtD
Nabumetone—Pruritus—Docetaxel—breast cancer	4.32e-05	0.000211	CcSEcCtD
Nabumetone—Anaemia—Doxorubicin—breast cancer	4.31e-05	0.00021	CcSEcCtD
Nabumetone—Thrombocytopenia—Methotrexate—breast cancer	4.31e-05	0.00021	CcSEcCtD
Nabumetone—Agitation—Doxorubicin—breast cancer	4.29e-05	0.000209	CcSEcCtD
Nabumetone—Anxiety—Epirubicin—breast cancer	4.28e-05	0.000209	CcSEcCtD
Nabumetone—Nausea—Paclitaxel—breast cancer	4.28e-05	0.000209	CcSEcCtD
Nabumetone—Hyperhidrosis—Methotrexate—breast cancer	4.25e-05	0.000207	CcSEcCtD
Nabumetone—Discomfort—Epirubicin—breast cancer	4.24e-05	0.000207	CcSEcCtD
Nabumetone—Asthenia—Capecitabine—breast cancer	4.24e-05	0.000207	CcSEcCtD
Nabumetone—Malaise—Doxorubicin—breast cancer	4.21e-05	0.000205	CcSEcCtD
Nabumetone—Dry mouth—Epirubicin—breast cancer	4.2e-05	0.000205	CcSEcCtD
Nabumetone—Vertigo—Doxorubicin—breast cancer	4.19e-05	0.000205	CcSEcCtD
Nabumetone—Anorexia—Methotrexate—breast cancer	4.19e-05	0.000205	CcSEcCtD
Nabumetone—Syncope—Doxorubicin—breast cancer	4.19e-05	0.000204	CcSEcCtD
Nabumetone—Pruritus—Capecitabine—breast cancer	4.18e-05	0.000204	CcSEcCtD
Nabumetone—Leukopenia—Doxorubicin—breast cancer	4.18e-05	0.000204	CcSEcCtD
Nabumetone—Diarrhoea—Docetaxel—breast cancer	4.18e-05	0.000204	CcSEcCtD
Nabumetone—Confusional state—Epirubicin—breast cancer	4.15e-05	0.000202	CcSEcCtD
Nabumetone—Palpitations—Doxorubicin—breast cancer	4.12e-05	0.000201	CcSEcCtD
Nabumetone—Anaphylactic shock—Epirubicin—breast cancer	4.12e-05	0.000201	CcSEcCtD
Nabumetone—Oedema—Epirubicin—breast cancer	4.12e-05	0.000201	CcSEcCtD
Nabumetone—Loss of consciousness—Doxorubicin—breast cancer	4.1e-05	0.0002	CcSEcCtD
Nabumetone—Cough—Doxorubicin—breast cancer	4.07e-05	0.000199	CcSEcCtD
Nabumetone—Shock—Epirubicin—breast cancer	4.05e-05	0.000198	CcSEcCtD
Nabumetone—Diarrhoea—Capecitabine—breast cancer	4.04e-05	0.000197	CcSEcCtD
Nabumetone—Dizziness—Docetaxel—breast cancer	4.04e-05	0.000197	CcSEcCtD
Nabumetone—Thrombocytopenia—Epirubicin—breast cancer	4.03e-05	0.000197	CcSEcCtD
Nabumetone—Hypertension—Doxorubicin—breast cancer	4.03e-05	0.000197	CcSEcCtD
Nabumetone—Hyperhidrosis—Epirubicin—breast cancer	3.98e-05	0.000194	CcSEcCtD
Nabumetone—Insomnia—Methotrexate—breast cancer	3.98e-05	0.000194	CcSEcCtD
Nabumetone—Anxiety—Doxorubicin—breast cancer	3.96e-05	0.000193	CcSEcCtD
Nabumetone—Paraesthesia—Methotrexate—breast cancer	3.95e-05	0.000193	CcSEcCtD
Nabumetone—Discomfort—Doxorubicin—breast cancer	3.93e-05	0.000191	CcSEcCtD
Nabumetone—Anorexia—Epirubicin—breast cancer	3.92e-05	0.000191	CcSEcCtD
Nabumetone—Dyspnoea—Methotrexate—breast cancer	3.92e-05	0.000191	CcSEcCtD
Nabumetone—Somnolence—Methotrexate—breast cancer	3.91e-05	0.000191	CcSEcCtD
Nabumetone—Dizziness—Capecitabine—breast cancer	3.91e-05	0.000191	CcSEcCtD
Nabumetone—Dry mouth—Doxorubicin—breast cancer	3.89e-05	0.00019	CcSEcCtD
Nabumetone—Vomiting—Docetaxel—breast cancer	3.88e-05	0.000189	CcSEcCtD
Nabumetone—Dyspepsia—Methotrexate—breast cancer	3.87e-05	0.000189	CcSEcCtD
Nabumetone—Rash—Docetaxel—breast cancer	3.85e-05	0.000188	CcSEcCtD
Nabumetone—Dermatitis—Docetaxel—breast cancer	3.84e-05	0.000188	CcSEcCtD
Nabumetone—Confusional state—Doxorubicin—breast cancer	3.84e-05	0.000187	CcSEcCtD
Nabumetone—Decreased appetite—Methotrexate—breast cancer	3.82e-05	0.000187	CcSEcCtD
Nabumetone—Headache—Docetaxel—breast cancer	3.82e-05	0.000186	CcSEcCtD
Nabumetone—Anaphylactic shock—Doxorubicin—breast cancer	3.81e-05	0.000186	CcSEcCtD
Nabumetone—Oedema—Doxorubicin—breast cancer	3.81e-05	0.000186	CcSEcCtD
Nabumetone—Fatigue—Methotrexate—breast cancer	3.79e-05	0.000185	CcSEcCtD
Nabumetone—Vomiting—Capecitabine—breast cancer	3.76e-05	0.000183	CcSEcCtD
Nabumetone—Shock—Doxorubicin—breast cancer	3.75e-05	0.000183	CcSEcCtD
Nabumetone—Thrombocytopenia—Doxorubicin—breast cancer	3.73e-05	0.000182	CcSEcCtD
Nabumetone—Rash—Capecitabine—breast cancer	3.73e-05	0.000182	CcSEcCtD
Nabumetone—Insomnia—Epirubicin—breast cancer	3.72e-05	0.000182	CcSEcCtD
Nabumetone—Dermatitis—Capecitabine—breast cancer	3.72e-05	0.000182	CcSEcCtD
Nabumetone—Headache—Capecitabine—breast cancer	3.7e-05	0.000181	CcSEcCtD
Nabumetone—Paraesthesia—Epirubicin—breast cancer	3.7e-05	0.00018	CcSEcCtD
Nabumetone—Hyperhidrosis—Doxorubicin—breast cancer	3.68e-05	0.00018	CcSEcCtD
Nabumetone—Dyspnoea—Epirubicin—breast cancer	3.67e-05	0.000179	CcSEcCtD
Nabumetone—Somnolence—Epirubicin—breast cancer	3.66e-05	0.000178	CcSEcCtD
Nabumetone—Anorexia—Doxorubicin—breast cancer	3.63e-05	0.000177	CcSEcCtD
Nabumetone—Nausea—Docetaxel—breast cancer	3.63e-05	0.000177	CcSEcCtD
Nabumetone—Feeling abnormal—Methotrexate—breast cancer	3.62e-05	0.000177	CcSEcCtD
Nabumetone—Dyspepsia—Epirubicin—breast cancer	3.62e-05	0.000177	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methotrexate—breast cancer	3.6e-05	0.000175	CcSEcCtD
Nabumetone—Decreased appetite—Epirubicin—breast cancer	3.58e-05	0.000175	CcSEcCtD
Nabumetone—Fatigue—Epirubicin—breast cancer	3.55e-05	0.000173	CcSEcCtD
Nabumetone—Constipation—Epirubicin—breast cancer	3.52e-05	0.000172	CcSEcCtD
Nabumetone—Nausea—Capecitabine—breast cancer	3.51e-05	0.000171	CcSEcCtD
Nabumetone—Urticaria—Methotrexate—breast cancer	3.49e-05	0.00017	CcSEcCtD
Nabumetone—Abdominal pain—Methotrexate—breast cancer	3.48e-05	0.00017	CcSEcCtD
Nabumetone—Body temperature increased—Methotrexate—breast cancer	3.48e-05	0.00017	CcSEcCtD
Nabumetone—Insomnia—Doxorubicin—breast cancer	3.45e-05	0.000168	CcSEcCtD
Nabumetone—Paraesthesia—Doxorubicin—breast cancer	3.42e-05	0.000167	CcSEcCtD
Nabumetone—Dyspnoea—Doxorubicin—breast cancer	3.4e-05	0.000166	CcSEcCtD
Nabumetone—Feeling abnormal—Epirubicin—breast cancer	3.39e-05	0.000165	CcSEcCtD
Nabumetone—Somnolence—Doxorubicin—breast cancer	3.39e-05	0.000165	CcSEcCtD
Nabumetone—Gastrointestinal pain—Epirubicin—breast cancer	3.37e-05	0.000164	CcSEcCtD
Nabumetone—Dyspepsia—Doxorubicin—breast cancer	3.35e-05	0.000164	CcSEcCtD
Nabumetone—Decreased appetite—Doxorubicin—breast cancer	3.31e-05	0.000161	CcSEcCtD
Nabumetone—Fatigue—Doxorubicin—breast cancer	3.28e-05	0.00016	CcSEcCtD
Nabumetone—Urticaria—Epirubicin—breast cancer	3.27e-05	0.00016	CcSEcCtD
Nabumetone—Constipation—Doxorubicin—breast cancer	3.26e-05	0.000159	CcSEcCtD
Nabumetone—Abdominal pain—Epirubicin—breast cancer	3.25e-05	0.000159	CcSEcCtD
Nabumetone—Body temperature increased—Epirubicin—breast cancer	3.25e-05	0.000159	CcSEcCtD
Nabumetone—Hypersensitivity—Methotrexate—breast cancer	3.24e-05	0.000158	CcSEcCtD
Nabumetone—Asthenia—Methotrexate—breast cancer	3.16e-05	0.000154	CcSEcCtD
Nabumetone—Feeling abnormal—Doxorubicin—breast cancer	3.14e-05	0.000153	CcSEcCtD
Nabumetone—Gastrointestinal pain—Doxorubicin—breast cancer	3.11e-05	0.000152	CcSEcCtD
Nabumetone—Pruritus—Methotrexate—breast cancer	3.11e-05	0.000152	CcSEcCtD
Nabumetone—Hypersensitivity—Epirubicin—breast cancer	3.03e-05	0.000148	CcSEcCtD
Nabumetone—Urticaria—Doxorubicin—breast cancer	3.03e-05	0.000148	CcSEcCtD
Nabumetone—Abdominal pain—Doxorubicin—breast cancer	3.01e-05	0.000147	CcSEcCtD
Nabumetone—Body temperature increased—Doxorubicin—breast cancer	3.01e-05	0.000147	CcSEcCtD
Nabumetone—Diarrhoea—Methotrexate—breast cancer	3.01e-05	0.000147	CcSEcCtD
Nabumetone—Asthenia—Epirubicin—breast cancer	2.95e-05	0.000144	CcSEcCtD
Nabumetone—Pruritus—Epirubicin—breast cancer	2.91e-05	0.000142	CcSEcCtD
Nabumetone—Dizziness—Methotrexate—breast cancer	2.91e-05	0.000142	CcSEcCtD
Nabumetone—Diarrhoea—Epirubicin—breast cancer	2.82e-05	0.000137	CcSEcCtD
Nabumetone—Hypersensitivity—Doxorubicin—breast cancer	2.81e-05	0.000137	CcSEcCtD
Nabumetone—Vomiting—Methotrexate—breast cancer	2.8e-05	0.000136	CcSEcCtD
Nabumetone—Rash—Methotrexate—breast cancer	2.77e-05	0.000135	CcSEcCtD
Nabumetone—Dermatitis—Methotrexate—breast cancer	2.77e-05	0.000135	CcSEcCtD
Nabumetone—Headache—Methotrexate—breast cancer	2.76e-05	0.000134	CcSEcCtD
Nabumetone—Asthenia—Doxorubicin—breast cancer	2.73e-05	0.000133	CcSEcCtD
Nabumetone—Dizziness—Epirubicin—breast cancer	2.72e-05	0.000133	CcSEcCtD
Nabumetone—Pruritus—Doxorubicin—breast cancer	2.69e-05	0.000131	CcSEcCtD
Nabumetone—Vomiting—Epirubicin—breast cancer	2.62e-05	0.000128	CcSEcCtD
Nabumetone—Nausea—Methotrexate—breast cancer	2.61e-05	0.000127	CcSEcCtD
Nabumetone—Diarrhoea—Doxorubicin—breast cancer	2.61e-05	0.000127	CcSEcCtD
Nabumetone—Rash—Epirubicin—breast cancer	2.6e-05	0.000127	CcSEcCtD
Nabumetone—Dermatitis—Epirubicin—breast cancer	2.59e-05	0.000126	CcSEcCtD
Nabumetone—Headache—Epirubicin—breast cancer	2.58e-05	0.000126	CcSEcCtD
Nabumetone—Dizziness—Doxorubicin—breast cancer	2.52e-05	0.000123	CcSEcCtD
Nabumetone—Nausea—Epirubicin—breast cancer	2.45e-05	0.000119	CcSEcCtD
Nabumetone—Vomiting—Doxorubicin—breast cancer	2.42e-05	0.000118	CcSEcCtD
Nabumetone—Rash—Doxorubicin—breast cancer	2.4e-05	0.000117	CcSEcCtD
Nabumetone—Dermatitis—Doxorubicin—breast cancer	2.4e-05	0.000117	CcSEcCtD
Nabumetone—Headache—Doxorubicin—breast cancer	2.39e-05	0.000116	CcSEcCtD
Nabumetone—Nausea—Doxorubicin—breast cancer	2.26e-05	0.00011	CcSEcCtD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.31e-05	0.000142	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—FASN—breast cancer	1.3e-05	0.000141	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—BCHE—breast cancer	1.29e-05	0.000141	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC5A5—breast cancer	1.28e-05	0.000139	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NCOA3—breast cancer	1.27e-05	0.000139	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC2A2—breast cancer	1.27e-05	0.000138	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ANGPTL4—breast cancer	1.26e-05	0.000137	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ESRRA—breast cancer	1.26e-05	0.000137	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.25e-05	0.000136	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF3—breast cancer	1.25e-05	0.000136	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCG2—breast cancer	1.24e-05	0.000135	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CPT1A—breast cancer	1.24e-05	0.000135	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTR—breast cancer	1.24e-05	0.000135	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NQO1—breast cancer	1.24e-05	0.000134	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC2A1—breast cancer	1.24e-05	0.000134	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FASN—breast cancer	1.23e-05	0.000134	CbGpPWpGaD
Nabumetone—PTGS2—Disease—JAG1—breast cancer	1.23e-05	0.000134	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PARP1—breast cancer	1.23e-05	0.000133	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HPGDS—breast cancer	1.22e-05	0.000132	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CALCA—breast cancer	1.21e-05	0.000132	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.21e-05	0.000131	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HBA1—breast cancer	1.21e-05	0.000131	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP3A4—breast cancer	1.2e-05	0.000131	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.2e-05	0.00013	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPS6—breast cancer	1.2e-05	0.00013	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.19e-05	0.00013	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPI—breast cancer	1.19e-05	0.000129	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HADHB—breast cancer	1.19e-05	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF4—breast cancer	1.19e-05	0.000129	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP1B1—breast cancer	1.18e-05	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CXCR4—breast cancer	1.18e-05	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ACHE—breast cancer	1.18e-05	0.000128	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTT1—breast cancer	1.18e-05	0.000128	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC2A1—breast cancer	1.17e-05	0.000127	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HSP90AA1—breast cancer	1.16e-05	0.000126	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.14e-05	0.000124	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TCF7L2—breast cancer	1.14e-05	0.000124	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.14e-05	0.000124	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDH7A1—breast cancer	1.14e-05	0.000124	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDH1A1—breast cancer	1.14e-05	0.000124	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NCOA1—breast cancer	1.13e-05	0.000123	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.12e-05	0.000122	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP17A1—breast cancer	1.12e-05	0.000121	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—STK11—breast cancer	1.11e-05	0.000121	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP19A1—breast cancer	1.11e-05	0.000121	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ENO1—breast cancer	1.11e-05	0.00012	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PTGS1—breast cancer	1.11e-05	0.00012	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.1e-05	0.00012	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HSP90AA1—breast cancer	1.1e-05	0.00012	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADSL—breast cancer	1.09e-05	0.000118	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NME1—breast cancer	1.09e-05	0.000118	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—FHL2—breast cancer	1.09e-05	0.000118	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—UMPS—breast cancer	1.09e-05	0.000118	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PHGDH—breast cancer	1.09e-05	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.09e-05	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2D6—breast cancer	1.08e-05	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRL—breast cancer	1.07e-05	0.000116	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HPSE—breast cancer	1.07e-05	0.000116	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LDHB—breast cancer	1.07e-05	0.000116	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—BRIP1—breast cancer	1.07e-05	0.000116	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NCOA2—breast cancer	1.06e-05	0.000116	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ADAM10—breast cancer	1.06e-05	0.000115	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.04e-05	0.000114	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—COMT—breast cancer	1.03e-05	0.000113	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—FASN—breast cancer	1.03e-05	0.000112	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTP1—breast cancer	1.03e-05	0.000112	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—BCHE—breast cancer	1.03e-05	0.000112	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF10—breast cancer	1.03e-05	0.000112	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMOX1—breast cancer	1.02e-05	0.00011	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC5A5—breast cancer	1.02e-05	0.00011	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ITPR1—breast cancer	1.01e-05	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMMR—breast cancer	1.01e-05	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA3—breast cancer	1.01e-05	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCC1—breast cancer	1.01e-05	0.00011	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PDGFA—breast cancer	9.91e-06	0.000108	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARGC1B—breast cancer	9.81e-06	0.000107	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NQO1—breast cancer	9.8e-06	0.000107	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC2A1—breast cancer	9.8e-06	0.000107	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFBR2—breast cancer	9.76e-06	0.000106	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCB1—breast cancer	9.75e-06	0.000106	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ITPR1—breast cancer	9.61e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	9.6e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TYMS—breast cancer	9.58e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP3A4—breast cancer	9.56e-06	0.000104	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	9.55e-06	0.000104	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	9.55e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERBB4—breast cancer	9.54e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT5A—breast cancer	9.54e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NCOR1—breast cancer	9.47e-06	0.000103	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTM1—breast cancer	9.47e-06	0.000103	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLA2G4A—breast cancer	9.47e-06	0.000103	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP1B1—breast cancer	9.4e-06	0.000102	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA4—breast cancer	9.26e-06	0.000101	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CA9—breast cancer	9.26e-06	0.000101	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SMAD4—breast cancer	9.24e-06	0.000101	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HSP90AA1—breast cancer	9.22e-06	0.0001	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	9.14e-06	9.94e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GPX1—breast cancer	9.06e-06	9.86e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	9.05e-06	9.84e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPX2—breast cancer	9.03e-06	9.81e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA2—breast cancer	9.03e-06	9.81e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HES1—breast cancer	9.02e-06	9.81e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP1A1—breast cancer	8.97e-06	9.76e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NCOR1—breast cancer	8.97e-06	9.76e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NCOA1—breast cancer	8.97e-06	9.75e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPX4—breast cancer	8.91e-06	9.69e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SULT1A1—breast cancer	8.91e-06	9.69e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ERCC2—breast cancer	8.9e-06	9.68e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF1—breast cancer	8.87e-06	9.65e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—STK11—breast cancer	8.84e-06	9.61e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP19A1—breast cancer	8.84e-06	9.61e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NRG1—breast cancer	8.81e-06	9.58e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—H2AFX—breast cancer	8.74e-06	9.51e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA1—breast cancer	8.71e-06	9.47e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—IDH1—breast cancer	8.71e-06	9.47e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NAT2—breast cancer	8.61e-06	9.36e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERCC2—breast cancer	8.44e-06	9.17e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTHFR—breast cancer	8.37e-06	9.1e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.3e-06	9.02e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERBB3—breast cancer	8.25e-06	8.97e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGFR2—breast cancer	8.24e-06	8.96e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—COMT—breast cancer	8.22e-06	8.93e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTP1—breast cancer	8.18e-06	8.89e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMOX1—breast cancer	8.06e-06	8.77e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ITPR1—breast cancer	8.05e-06	8.75e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTHFR—breast cancer	7.93e-06	8.62e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TERT—breast cancer	7.91e-06	8.6e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	7.78e-06	8.46e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCB1—breast cancer	7.74e-06	8.42e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CAV1—breast cancer	7.72e-06	8.39e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGFR1—breast cancer	7.68e-06	8.35e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TYMS—breast cancer	7.6e-06	8.27e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HIF1A—breast cancer	7.56e-06	8.22e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MED12—breast cancer	7.55e-06	8.21e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DPYD—breast cancer	7.55e-06	8.21e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLA2G4A—breast cancer	7.51e-06	8.17e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTM1—breast cancer	7.51e-06	8.17e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NCOR1—breast cancer	7.51e-06	8.17e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDOA—breast cancer	7.43e-06	8.08e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.37e-06	8.02e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CAV1—breast cancer	7.31e-06	7.95e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NCOA3—breast cancer	7.22e-06	7.85e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GPX1—breast cancer	7.2e-06	7.82e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC2A2—breast cancer	7.16e-06	7.79e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP1A1—breast cancer	7.12e-06	7.75e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.09e-06	7.71e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ERCC2—breast cancer	7.07e-06	7.68e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CG—breast cancer	7.03e-06	7.64e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCG2—breast cancer	7.02e-06	7.63e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CPT1A—breast cancer	7.02e-06	7.63e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTR—breast cancer	7.02e-06	7.63e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HPGDS—breast cancer	6.88e-06	7.48e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS2—breast cancer	6.88e-06	7.48e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HBA1—breast cancer	6.84e-06	7.44e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOTCH1—breast cancer	6.81e-06	7.41e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTT1—breast cancer	6.68e-06	7.26e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ACHE—breast cancer	6.68e-06	7.26e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KIT—breast cancer	6.66e-06	7.24e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APC—breast cancer	6.66e-06	7.24e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTHFR—breast cancer	6.64e-06	7.22e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EGF—breast cancer	6.59e-06	7.16e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP17A1—breast cancer	6.32e-06	6.87e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—BRAF—breast cancer	6.26e-06	6.81e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ENO1—breast cancer	6.26e-06	6.8e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS1—breast cancer	6.26e-06	6.8e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.23e-06	6.78e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CD—breast cancer	6.18e-06	6.72e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.15e-06	6.69e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2D6—breast cancer	6.13e-06	6.67e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CAV1—breast cancer	6.13e-06	6.66e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—breast cancer	6.1e-06	6.63e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT2—breast cancer	6.1e-06	6.63e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NCOA2—breast cancer	6.02e-06	6.55e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CD—breast cancer	5.86e-06	6.37e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.85e-06	6.36e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—FASN—breast cancer	5.84e-06	6.35e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NOS3—breast cancer	5.83e-06	6.34e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—BCHE—breast cancer	5.82e-06	6.32e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SERPINE1—breast cancer	5.79e-06	6.3e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC5A5—breast cancer	5.74e-06	6.25e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CG—breast cancer	5.58e-06	6.07e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NQO1—breast cancer	5.55e-06	6.03e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC2A1—breast cancer	5.55e-06	6.03e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS3—breast cancer	5.53e-06	6.01e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.43e-06	5.91e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP3A4—breast cancer	5.41e-06	5.88e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CB—breast cancer	5.39e-06	5.86e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.38e-06	5.85e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—breast cancer	5.34e-06	5.8e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP1B1—breast cancer	5.32e-06	5.78e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MDM2—breast cancer	5.25e-06	5.71e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RAF1—breast cancer	5.23e-06	5.69e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HSP90AA1—breast cancer	5.22e-06	5.67e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERBB2—breast cancer	5.17e-06	5.63e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CB—breast cancer	5.11e-06	5.55e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTOR—breast cancer	5.11e-06	5.55e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD4—breast cancer	5.1e-06	5.54e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NCOA1—breast cancer	5.07e-06	5.52e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—STK11—breast cancer	5e-06	5.44e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP19A1—breast cancer	5e-06	5.44e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CD—breast cancer	4.91e-06	5.33e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—breast cancer	4.84e-06	5.27e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1B—breast cancer	4.79e-06	5.21e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.69e-06	5.1e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTEN—breast cancer	4.65e-06	5.06e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—COMT—breast cancer	4.65e-06	5.06e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NOS3—breast cancer	4.63e-06	5.04e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTP1—breast cancer	4.63e-06	5.03e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMOX1—breast cancer	4.56e-06	4.96e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ITPR1—breast cancer	4.55e-06	4.95e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CTNNB1—breast cancer	4.53e-06	4.92e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1A—breast cancer	4.42e-06	4.81e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PTEN—breast cancer	4.41e-06	4.8e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCB1—breast cancer	4.38e-06	4.76e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TYMS—breast cancer	4.3e-06	4.68e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CB—breast cancer	4.28e-06	4.65e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM1—breast cancer	4.25e-06	4.62e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLA2G4A—breast cancer	4.25e-06	4.62e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NCOR1—breast cancer	4.25e-06	4.62e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SRC—breast cancer	4.09e-06	4.45e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPX1—breast cancer	4.07e-06	4.43e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP1A1—breast cancer	4.03e-06	4.38e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ERCC2—breast cancer	4e-06	4.35e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT3—breast cancer	3.95e-06	4.29e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAPK3—breast cancer	3.77e-06	4.1e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTHFR—breast cancer	3.76e-06	4.09e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PTEN—breast cancer	3.69e-06	4.02e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MYC—breast cancer	3.67e-06	3.99e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFB1—breast cancer	3.66e-06	3.98e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EGFR—breast cancer	3.59e-06	3.9e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CAV1—breast cancer	3.47e-06	3.77e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KRAS—breast cancer	3.39e-06	3.68e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.31e-06	3.6e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CA—breast cancer	3.28e-06	3.57e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CG—breast cancer	3.16e-06	3.43e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CA—breast cancer	3.11e-06	3.38e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HRAS—breast cancer	2.88e-06	3.13e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CD—breast cancer	2.78e-06	3.02e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—breast cancer	2.76e-06	3e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—breast cancer	2.74e-06	2.98e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKT1—breast cancer	2.68e-06	2.92e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NOS3—breast cancer	2.62e-06	2.85e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CA—breast cancer	2.61e-06	2.83e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT1—breast cancer	2.54e-06	2.76e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CB—breast cancer	2.42e-06	2.63e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—breast cancer	2.4e-06	2.61e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKT1—breast cancer	2.13e-06	2.32e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTEN—breast cancer	2.09e-06	2.27e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CA—breast cancer	1.47e-06	1.6e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKT1—breast cancer	1.2e-06	1.31e-05	CbGpPWpGaD
